Improdia logo — A diagnostic company, develops clusters of biomarkers for im...

Improdia

A diagnostic company, develops clusters of biomarkers for immune status monitoring for chronical patients

Founded 2012 Israel Israel 1 employees Seed Total: $3.00M Health Care

General Information

Company Name Improdia
Founded Year 2012
Location Israel Israel
Employees 1
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Improdia. To contact Improdia, visit improdia.co.il.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Improdia compare?

A PDF of Improdia and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Improdia soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Improdia

Improdia is an innovative, diagnostic company that develops clusters of novel proprietary biomarkers for monitoring the Immune Status of patients suffering from diseases associated with Chronic Inflammation.

Taxonomy: Diagnostic company, Biomarkers, Immune status monitoring, Chronic inflammation, Personalized treatments, Blood test, Non-invasive, Medical field, Immune status detection, Innovative, Proprietary biomarkers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round ILS3.00M -
15 Oct 2014

Improdia Alternatives & Competitors

View All Alternatives
Improdia vs

At JaxBio we develop a blood test for fast, cheap and highly sensitive diagnosis of cancer.

Grant
11 employees
Health Care
Improdia vs
Omini
Omini France

Multiplex blood testing platform to monitor chronic diseases like heart failure Project co-funded by...

58 employees
Biotechnology, Health Care
Improdia vs
EnLiSense LLC
EnLiSense LLC United States

EnLiSense biosensors and platform technologies enables tracking of WELLNESS to ILLNESS and back to W...

Grant
7 employees
Health Care, Manufacturing

FAQ About Improdia

A diagnostic company, develops clusters of biomarkers for immune status monitoring for chronical patients
Improdia was founded in 2012.
Improdia is headquartered in Israel.
Improdia operates in Health Care. Its work centres on Diagnostic company, Biomarkers, Immune status monitoring and Chronic inflammation.
Improdia has approximately 1 employees.
Improdia has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Seed.
Top alternatives and competitors to Improdia include JaxBio, Omini, EnLiSense LLC, True Diagnostics™, Odin Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Improdia and JaxBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Improdia, https://bouncewatch.com/company/improdia, updated 13 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes